Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Clobetasol
Drug ID BADD_D00489
Description Clobetasol is under investigation for the treatment of Scleroderma. Clobetasol has been investigated for the prevention of Psoriasis and Cutaneous Atrophy Due to Corticosteroids.
Indications and Usage Not Available
Marketing Status approved; experimental; investigational
ATC Code D07AD01
DrugBank ID DB11750
KEGG ID D07715
MeSH ID D002990
PubChem ID 5311051
TTD Drug ID D0FL5V
NDC Product Code Not Available
UNII ADN79D536H
Synonyms Clobetasol | Clofenazon | Clobetasol Propionate | Clobetasol 17-Propionate | Clobetasol 17 Propionate | Clobex | Cormax | OLUX | Dermovate | Embeline | Embeline E | Temovate
Chemical Information
Molecular Formula C22H28ClFO4
CAS Registry Number 25122-41-2
SMILES CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)O)C)O)F)C
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Lichenification23.03.08.010--Not Available
Miliaria23.02.03.014--Not Available
Nasopharyngitis22.07.03.002; 11.01.13.002--Not Available
Nausea07.01.07.001--
Oedema14.05.06.010; 08.01.07.006--Not Available
Pain08.01.08.004--
Pain of skin23.03.03.003--
Paraesthesia23.03.03.094; 17.02.06.005--
Pharyngitis streptococcal11.02.06.002; 22.07.04.001--Not Available
Pruritus23.03.12.001--
Psoriasis23.03.14.002; 10.02.01.036--Not Available
Rash23.03.13.001--Not Available
Rash pustular23.03.10.003; 11.01.12.002--
Secondary adrenocortical insufficiency14.11.01.014; 05.03.04.012--Not Available
Skin atrophy23.01.05.001--
Skin disorder23.03.03.007--Not Available
Skin exfoliation23.03.07.003--Not Available
Skin fissures23.03.03.008--Not Available
Skin irritation23.03.04.009--Not Available
Skin striae23.01.05.002--Not Available
Telangiectasia24.03.03.003; 23.06.03.001--
Tenderness08.01.08.005--Not Available
Upper respiratory tract infection22.07.03.011; 11.01.13.009--
Urticaria23.04.02.001; 10.01.06.001--
Vision blurred17.17.01.010; 06.02.06.007--
Application site dryness12.07.01.011; 08.02.01.011; 23.03.03.024--Not Available
Skin tightness23.03.03.018--Not Available
Asteatosis23.02.07.006--Not Available
Application site discolouration23.03.03.023; 12.07.01.030; 08.02.01.030--Not Available
Induration08.01.03.020--Not Available
The 2th Page    First    Pre   2 3    Next   Last    Total 3 Pages